DCGI gives EUA to India’s first nasal vaccine against COVID-19
BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.